Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 18 (RPL31P18)

Target: RPL31P18
Molecular classification: Other (Pseudogene)

Overview

RPL31P18 is a processed pseudogene corresponding to the ribosomal protein L31 gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they generally do not encode functional proteins and are not involved in canonical biological pathways or therapeutic targeting. RPL31P18 does not appear to be involved in protein synthesis, cell signaling, or associated with disease phenotypes. There is no evidence supporting its use as a drug target, biomarker, or therapeutic concern in scientific literature.

Other names: RPL31_7_358RPL31P18

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 18 (RPL31P18).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 18 (RPL31P18).

Explore the full profile